![Figure 2. | Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma | Cancer Research Figure 2. | Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma | Cancer Research](https://cancerres.aacrjournals.org/content/76/23/6901/F2.large.jpg)
Figure 2. | Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma | Cancer Research
![Survival by light chain type for IgG and IgA myeloma stratified by the... | Download Scientific Diagram Survival by light chain type for IgG and IgA myeloma stratified by the... | Download Scientific Diagram](https://www.researchgate.net/profile/Mark_Drayson/publication/7053433/figure/fig6/AS:280657927393280@1443925472049/Survival-by-light-chain-type-for-IgG-and-IgA-myeloma-stratified-by-the-presence-or_Q640.jpg)
Survival by light chain type for IgG and IgA myeloma stratified by the... | Download Scientific Diagram
The changes of serum IgA, free kappa/lambda ratio, creatinine and free... | Download Scientific Diagram
![Cureus | A Patient of Multiple Myeloma with Absent M-spike on Serum Protein Electrophoresis and Elevated Serum-Free Light Chains: A Case Report and Literature Review Cureus | A Patient of Multiple Myeloma with Absent M-spike on Serum Protein Electrophoresis and Elevated Serum-Free Light Chains: A Case Report and Literature Review](https://assets.cureus.com/uploads/figure/file/74982/d5106e10afa111e9b2336b065d634a0d-Webp.net-resizeimage-_6_.jpg)
Cureus | A Patient of Multiple Myeloma with Absent M-spike on Serum Protein Electrophoresis and Elevated Serum-Free Light Chains: A Case Report and Literature Review
![Elotuzumab: serum protein electrophoresis and immunofixation interference with clinical assessment of M-protein response in relapsed/refractory multiple myeloma (RRMM) - Clinical Lymphoma, Myeloma and Leukemia Elotuzumab: serum protein electrophoresis and immunofixation interference with clinical assessment of M-protein response in relapsed/refractory multiple myeloma (RRMM) - Clinical Lymphoma, Myeloma and Leukemia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e021233e-e936-4d23-9cd0-22d608c5fb4e/fx1.jpg)
Elotuzumab: serum protein electrophoresis and immunofixation interference with clinical assessment of M-protein response in relapsed/refractory multiple myeloma (RRMM) - Clinical Lymphoma, Myeloma and Leukemia
![Myeloma kidney: the importance of assessing the response by monitoring free light chains in serum | Nefrología (English Edition) Myeloma kidney: the importance of assessing the response by monitoring free light chains in serum | Nefrología (English Edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/X2013251413053229:12103_16025_52994_en_f2121033.jpg?idApp=UINPBA000064)
Myeloma kidney: the importance of assessing the response by monitoring free light chains in serum | Nefrología (English Edition)
![A) A monoclonal peak is observed in the gammaglobulin fraction (7.73... | Download Scientific Diagram A) A monoclonal peak is observed in the gammaglobulin fraction (7.73... | Download Scientific Diagram](https://www.researchgate.net/profile/Seonghoon_Shin2/publication/51737633/figure/fig5/AS:214374972170254@1428122384417/A-A-monoclonal-peak-is-observed-in-the-gammaglobulin-fraction-773-g-dL-in-serum.png)
A) A monoclonal peak is observed in the gammaglobulin fraction (7.73... | Download Scientific Diagram
![Immunoglobulin G kappa biclonal gammopathy associated with multiple myeloma, plasmacytoma and cast nephropathy Pradhan D, Arora P, Gami A, Kaur N - J Can Res Ther Immunoglobulin G kappa biclonal gammopathy associated with multiple myeloma, plasmacytoma and cast nephropathy Pradhan D, Arora P, Gami A, Kaur N - J Can Res Ther](http://www.cancerjournal.net/articles/2015/11/3/images/JCanResTher_2015_11_3_660_139379_f5.jpg)